Kane, Sunanda
Kane, Sunanda V.
Sunanda Kane researcher
VIAF ID: 275617320 (Personal)
Permalink: http://viaf.org/viaf/275617320
Preferred Forms
- 100 1 _ ‡a Kane, Sunanda
- 100 1 _ ‡a Kane, Sunanda
-
-
- 100 1 _ ‡a Kane, Sunanda
-
- 100 1 _ ‡a Kane, Sunanda V.
- 100 1 _ ‡a Kane, Sunanda V.
- 100 0 _ ‡a Sunanda Kane ‡c researcher
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC) | |
Board review in gastroenterology, 2000: | |
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease | |
Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes | |
Editorial: is it time for therapeutic drug monitoring of anti-TNF agents during pregnancy? Maybe, maybe not. | |
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation | |
IBD self-management. | |
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort | |
Jelito cienkie, jelito grube, trzustka | |
Kaiyōsei daichōen kurōnbyō no chiryō seikatsu marugoto gaido : Amerika shōkakibyō gakkai no shishin ni motozuita jiko kanri no pointo | |
Mayo Clinic on Crohn's disease and ulcerative colitis | |
n2001127917 | |
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab | |
Pocket guide to inflammatory bowel disease | |
Practical gastroenterology and hepatology | |
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease | |
Small and large intestine and pancreas | |
Women's health in IBD : the spectrum of care from birth to adulthood | |
潰瘍性大腸炎・クローン病の治療・生活まるごとガイド : アメリカ消化器病学会の指針に基づいた自己管理のポイント |